Metabolic dysfunction-associated steatotic liver disease (MASLD) — previously known as "non-alcoholic fatty liver disease" — affects about 25% of the global population. The accumulation of ...
Non-alcoholic fatty liver disease (NAFLD) occurs when excess fat accumulates in liver cells in people who consume little or no alcohol. NAFLD is associated with various metabolic risk factors ...
Hepatic Disease: A Camu-Camu Fruit Extract to Reduce Liver Fat Aug. 21, 2024 — A research team has shown the benefits of camu-camu on non-alcoholic fatty liver disease. This exotic fruit reduces ...
Acute fatty liver of pregnancy (AFLP) is a rare obstetric complication, and despite improvements in recognition and management over recent decades, it still carries a high risk of maternal and fetal ...
As of March 2024, clinicaltrials.gov reported 150 registered trials on ‘Liver Diseases’ and ‘Microbiota,’ covering approximately 20 indications. Fatty liver disease, cirrhosis, liver failure, viral ...
Results A total of 12 studies (1 individual patient data analysis of 22 randomised controlled trials, 5 cohorts and 6 case–controls) were qualified for this meta-analysis, involving 5 640 313 ...